Postinfection Irritable Bowel Syndrome

키워드

참고문헌 (87)

1. Sperber AD, "Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study", Gastroenterology, 160, pp.99~114 (2021)
2. Gwee KA, "Irritable bowel syndrome in Asia : pathogenesis, natural history, epidemiology, and management", J Gastroenterol Hepatol, 33, pp.99~110 (2018)
3. Ghoshal UC, "Marshall and Warren Lecture 2019 : a paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment", J Gastroenterol Hepatol, 35, pp.712~721 (2020)
4. Drossman DA, "Rome IV-functional GI disorders : disorders of gut-brain interaction", Gastroenterology, 150, pp.1257~1261 (2016)
5. Barbara G, "The intestinal microenvironment and functional gastrointestinal disorders", Gastroenterology, 150, pp.1305~1318 (2016)
6. Barbara G, "Rome Foundation Working Team report on post-infection irritable bowel syndrome", Gastroenterology, 156, pp.46~58 (2019)
7. Schmulson M, "Managing the inevitable surge of post-COVID-19 functional gastrointestinal disorders", Am J Gastroenterol, 116, pp.4~7 (2021)
8. Kumar A, "Gastrointestinal and hepatic manifestations of corona virus disease-19 and their relationship to severe clinical course : a systematic review and meta-analysis", Indian J Gastroenterol, 39, pp.268~284 (2020)
9. Ghoshal UC, "The spectrum of gastrointestinal symptoms in patients with coronavirus disease-19 : predictors, relationship with disease severity, and outcome", Clin Transl Gastroenterol, 11, pp.e00259~ (2020)
10. Ghoshal UC, "Post-infection irritable bowel syndrome in the tropical and subtropical regions : Vibrio cholerae is a new cause of this well-known condition", Indian J Gastroenterol, 38, pp.87~94 (2019)
11. McKendrick MW, "Irritable bowel syndrome : post salmonella infection", J Infect, 29, pp.1~3 (1994)
12. Gwee KA, "Psychometric scores and persistence of irritable bowel after infectious diarrhoea", Lancet, 347, pp.150~153 (1996)
13. Gwee KA, "The role of psychological and biological factors in postinfective gut dysfunction", Gut, 44, pp.400~406 (1999)
14. Neal KR, "Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome : postal survey of patients", BMJ, 314, pp.779~782 (1997)
15. Rodríguez LA, "Increased risk of irritable bowel syndrome after bacterial gastroenteritis : cohort study", BMJ, 318, pp.565~566 (1999)
16. Mearin F, "Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak : one-year follow-up cohort study", Gastroenterology, 129, pp.98~104 (2005)
17. Ilnyckyj A, "Post-traveler’s diarrhea irritable bowel syndrome : a prospective study", Am J Gastroenterol, 98, pp.596~599 (2003)
18. Dunlop SP, "Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS", Gastroenterology, 125, pp.1651~1659 (2003)
19. Parry SD, "Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study", Am J Gastroenterol, 98, pp.1970~1975 (2003)
20. 김희선, "이질 감염 후 과민성 장증후군 발생: 3년 추적 연구", 대한소화기학회지, 47(4), pp.300~305 (2006), 대한소화기학회
21. Marshall JK, "Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery", Gastroenterology, 131, pp.445~450 (2006)
22. Borgaonkar MR, "The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection", Dig Dis Sci, 51, pp.1026~1032 (2006)
23. Stermer E, "Is traveler’s diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study", Clin Infect Dis, 43, pp.898~901 (2006)
24. Marshall JK, "Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen", Clin Gastroenterol Hepatol, 5, pp.457~460 (2007)
25. Spence MJ, "The cognitive behavioural model of irritable bowel syndrome : a prospective investigation of patients with gastroenteritis", Gut, 56, pp.1066~1071 (2007)
26. Hanevik K, "Development of functional gastrointestinal disorders after Giardia lamblia infection", BMC Gastroenterol, 9, pp.27~ (2009)
27. Zanini B, "Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak", Am J Gastroenterol, 107, pp.891~899 (2012)
28. Cremon C, "Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood", Gastroenterology, 147, pp.69~77 (2014)
29. Persson R, "The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome : a controlled study 6 years after acute gastrointestinal infection", BMC Gastroenterol, 15, pp.66~ (2015)
30. Wadhwa A, "High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection", Aliment Pharmacol Ther, 44, pp.576~582 (2016)
31. Andresen V, "Post-infectious irritable bowel syndrome(PI-IBS)after infection with Shigalike toxin-producing Escherichia coli(STEC)O104 : H4 : a cohort study with prospective follow-up", United European Gastroenterol J, 4, pp.121~131 (2016)
32. Rahman MM, "Long-term gastrointestinal consequences are frequent following sporadic acute infectious diarrhea in a tropical country : a prospective cohort study", Am J Gastroenterol, 113, pp.1363~1375 (2018)
33. Parida PK, "A prospective study on incidence, risk factors, and validation of a risk score for postinfection irritable bowel syndrome in coastal eastern India", Indian J Gastroenterol, 38, pp.134~142 (2019)
34. Wang LH, "Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis", Gut, 53, pp.1096~1101 (2004)
35. Okhuysen PC, "Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico", Am J Gastroenterol, 99, pp.1774~1778 (2004)
36. Ji S, "Post-infectious irritable bowel syndrome in patients with Shigella infection", J Gastroenterol Hepatol, 20, pp.381~386 (2005)
37. Parry SD, "Factors associated with the development of post-infectious functional gastrointestinal diseases : does smoking play a role?", Eur J Gastroenterol Hepatol, 17, pp.1071~1075 (2005)
38. Dormond M, "Giardia lamblia infection increases risk of chronic gastrointestinal disorders", Trop Dis Travel Med Vaccines, 2, pp.17~ (2016)
39. Iacob T, "Post-infectious irritable bowel syndrome after a laboratory-proven enteritis", Exp Ther Med, 20, pp.3517~3522 (2020)
40. Klem F, "Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis : a systematic review and meta-analysis", Gastroenterology, 152, pp.1042~1054 (2017)
41. Lacy BE, "Bowel disorders", Gastroenterology, 150, pp.1393~1407 (2016)
42. Thabane M, "Development and validation of a risk score for postinfectious irritable bowel syndrome", Am J Gastroenterol, 104, pp.2267~2274 (2009)
43. Jangra M, "Role of polymerase chain reaction in stool and duodenal biopsy for diagnosis of giardiasis in patients with persistent", chronic diarrhea, 2020, pp.65, 2345~2353
44. Ghoshal UC, "Spectrum of malabsorption syndrome among adults & factors differentiating celiac disease & tropical malabsorption", Indian J Med Res, 136, pp.451~459 (2012)
45. Porter CK, "Postinfectious gastrointestinal disorders following norovirus outbreaks", Clin Infect Dis, 55, pp.915~922 (2012)
46. Saps M, "Rotavirus gastroenteritis : precursor of functional gastrointestinal disorders?", J Pediatr Gastroenterol Nutr, 49, pp.580~583 (2009)
47. Wan Y, "Receptor recognition by the novel coronavirus from Wuhan : an analysis based on decade-long structural studies of SARS coronavirus", J Virol, 94, pp.e00127-20~ (2020)
48. Wong MC, "Detection of SARS-CoV-2 RNA in fecal specimens of patients with confirmed COVID-19 : a meta-analysis", J Infect, 81, pp.e31~e38 (2020)
49. Yeoh YK, "Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19", Gut, 70, pp.698~706 (2021)
50. Zuo T, "Alterations in gut microbiota of patients with COVID-19 during time of hospitalization", Gastroenterology, 159, pp.944~955 (2020)
51. Effenberger M, "Faecal calprotectin indicates intestinal inflammation in COVID-19", Gut, 69, pp.1543~1544 (2020)
52. Ha S, "Serotonin is elevated in COVID-19-associated diarrhoea", Gut, 70, pp.2015~2017 (2021)
53. Reza-Zaldívar EE, "Infection mechanism of SARS-COV-2 and its implication on the nervous system", Front Immunol, 11, pp.621735~ (2021)
54. Schurink B, "Viral presence and immunopathology in patients with lethal COVID-19 : a prospective autopsy cohort study", Lancet Microbe, 1, pp.e290~e299 (2020)
55. Twenge JM, "Mental distress among U. S. adults during the COVID-19 pandemic", J Clin Psychol, 76, pp.2170~2182 (2020)
56. Cardinale V, "Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2 : a working hypothesis", Dig Liver Dis, 52, pp.1383~1389 (2020)
57. Ghoshal UC, "Post-infectious irritable bowel syndrome : the past, the present and the future", J Gastroenterol Hepatol, 26(Suppl 3), pp.94~101 (2011)
58. Spiller RC, "Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome", Gut, 47, pp.804~811 (2000)
59. Hanning N, "Intestinal barrier dysfunction in irritable bowel syndrome : a systematic review", Therap Adv Gastroenterol, 14, pp.1756284821993586~ (2021)
60. Gwee KA, "Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome", Gut, 52, pp.523~526 (2003)
61. Jalanka-Tuovinen J, "Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome", Gut, 63, pp.1737~1745 (2014)
62. Downs IA, "Postinfection irritable bowel syndrome : the links between gastroenteritis, inflammation, the microbiome, and functional disease", J Clin Gastroenterol, 51, pp.869~877 (2017)
63. Villani AC, "Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis", Gastroenterology, 138, pp.1502~1513 (2010)
64. Swan C, "Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome(IBS) : association with TNFSF15 and TNFα", Gut, 62, pp.985~994 (2013)
65. Kumar S, "Serotonin transporter gene(SLC6A4)polymorphism in patients with irritable bowel syndrome and healthy controls", J Gastrointestin Liver Dis, 21, pp.31~38 (2012)
66. Gorbach SL, "Alterations in human intestinal microflora during experimental diarrhoea", Gut, 11, pp.1~6 (1970)
67. Sundin J, "Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress", Aliment Pharmacol Ther, 41, pp.342~351 (2015)
68. Jalanka J, "Microbial signatures in post-infectious irritable bowel syndrome : toward patient stratification for improved diagnostics and treatment", Gut Microbes, 6, pp.364~369 (2015)
69. De Palma G, "Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice", Sci Transl Med, 9, pp.eaaf6397~ (2017)
70. Ghoshal UC, "The gut microbiota and irritable bowel syndrome : friend or foe?", Int J Inflam, 2012, pp.151085~ (2012)
71. Ghoshal UC, "Small intestinal bacterial overgrowth and other intestinal disorders", Gastroenterol Clin North Am, 46, pp.103~120 (2017)
72. Wei L, "Gut microbiota dysbiosis in functional gastrointestinal disorders : underpinning the symptoms and pathophysiology", JGH Open, 5, pp.976~987 (2021)
73. Goyal O, "Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India", Indian J Gastroenterol, 40, pp.144~153 (2021)
74. Ghoshal UC, "Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time", J Gastroenterol Hepatol, 18, pp.540~547 (2003)
75. Ghoshal UC, "Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth : the missing link", Nat Rev Gastroenterol Hepatol, 14, pp.435~441 (2017)
76. Ghoshal UC, "A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome", J Gastroenterol Hepatol, 35, pp.922~931 (2020)
77. Rezaie A, "Assessment of antivinculin and anti-cytolethal distending toxin B antibodies in subtypes of irritable bowel syndrome", Dig Dis Sci, 62, pp.1480~1485 (2017)
78. Uday C Ghoshal, "Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros", Journal of Neurogastroenterology and Motility (JNM), 23(3), pp.334~340 (2017), 대한소화기 기능성질환∙운동학회[DOI]
79. Lam C, "A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea(IBS-D)", Gut, 65, pp.91~99 (2016)
80. Zhou Q, "Randomised placebocontrolled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome", Gut, 68, pp.996~1002 (2019)
81. Dunlop SP, "Randomized, doubleblind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome", Aliment Pharmacol Ther, 18, pp.77~84 (2003)
82. Harris LA, "Rifaximin for irritable bowel syndrome(IBS)in Gulf War veterans : losing the battle but winning the war?", Dig Dis Sci, 64, pp.609~610 (2019)
83. Tuteja AK, "Double-blind placebo-controlled study of rifaximin and lactulose hydrogen breath test in Gulf War veterans with irritable bowel syndrome", Dig Dis Sci, 64, pp.838~845 (2019)
84. Mehtab W, "All that a physician should know about FODMAPs", Indian J Gastroenterol, 38, pp.378~390 (2019)
85. Neal KR, "Prognosis in post-infective irritable bowel syndrome : a six year follow up study", Gut, 51, pp.410~413 (2002)
86. Jung IS, "The clinical course of postinfectious irritable bowel syndrome : a five-year followup study", J Clin Gastroenterol, 43, pp.534~540 (2009)
87. Thabane M, "Post-infectious irritable bowel syndrome", World J Gastroenterol, 15, pp.3591~3596 (2009)

관련 논문AI추천